DE60144027D1 - 5t4 rna in plasma und serum als marker für neoplastische erkrankungen - Google Patents

5t4 rna in plasma und serum als marker für neoplastische erkrankungen

Info

Publication number
DE60144027D1
DE60144027D1 DE60144027T DE60144027T DE60144027D1 DE 60144027 D1 DE60144027 D1 DE 60144027D1 DE 60144027 T DE60144027 T DE 60144027T DE 60144027 T DE60144027 T DE 60144027T DE 60144027 D1 DE60144027 D1 DE 60144027D1
Authority
DE
Germany
Prior art keywords
rna
serum
plasma
neoplastic
illnesses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60144027T
Other languages
English (en)
Inventor
Michael S Kopreski
Christopher D Gocke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OncoMEDx Inc
Original Assignee
OncoMEDx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/649,371 external-priority patent/US6794135B1/en
Application filed by OncoMEDx Inc filed Critical OncoMEDx Inc
Application granted granted Critical
Publication of DE60144027D1 publication Critical patent/DE60144027D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60144027T 2000-08-28 2001-08-21 5t4 rna in plasma und serum als marker für neoplastische erkrankungen Expired - Lifetime DE60144027D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/649,371 US6794135B1 (en) 1996-03-26 2000-08-28 Method for detection of 5T4 RNA in plasma or serum
PCT/US2001/026119 WO2002018645A2 (en) 2000-08-28 2001-08-21 5t4 rna in plasma and serum as a marker for neoplastic disease

Publications (1)

Publication Number Publication Date
DE60144027D1 true DE60144027D1 (de) 2011-03-24

Family

ID=24604503

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60144027T Expired - Lifetime DE60144027D1 (de) 2000-08-28 2001-08-21 5t4 rna in plasma und serum als marker für neoplastische erkrankungen

Country Status (6)

Country Link
US (2) US20050260594A1 (de)
EP (1) EP1354060B1 (de)
AT (1) ATE498020T1 (de)
AU (1) AU2001285157A1 (de)
DE (1) DE60144027D1 (de)
WO (1) WO2002018645A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1540002A2 (de) * 2002-09-12 2005-06-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Verfahren zum nachweis von mikro-metastasen
US8252529B2 (en) * 2008-06-12 2012-08-28 The Invention Science Fund I, Llc Methods for collecting and detecting oligonucleotides
US8252528B2 (en) * 2008-06-12 2012-08-28 The Invention Science Fund I, Llc Methods, compositions, and kits for collecting and detecting oligonucleotides
US8614057B2 (en) * 2008-06-12 2013-12-24 The Invention Science Fund I, Llc Methods for collecting and detecting oligonucleotides
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE123652T1 (de) * 1988-03-04 1995-06-15 Cancer Res Campaign Tech Antigene.
US5869053A (en) * 1988-03-04 1999-02-09 Cancer Research Campaign Technology, Ltd. 5T4 antigen from human trophoblasts
CA2120336C (en) * 1991-10-04 2007-04-24 Beverly S. Emanuel Detecting digeorge syndrome mutations
US6329179B1 (en) * 1996-03-26 2001-12-11 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US5939262A (en) * 1996-07-03 1999-08-17 Ambion, Inc. Ribonuclease resistant RNA preparation and utilization
GB9704444D0 (en) * 1997-03-04 1997-04-23 Isis Innovation Non-invasive prenatal diagnosis
US6664056B2 (en) * 2000-10-17 2003-12-16 The Chinese University Of Hong Kong Non-invasive prenatal monitoring
FR2839015A1 (fr) * 2002-04-29 2003-10-31 Conception & Dev Michelin Sa Bandage flexible non pneumatique
CN101245376A (zh) * 2003-01-17 2008-08-20 香港中文大学 作为妊娠相关病症的诊断标志物的循环mRNA

Also Published As

Publication number Publication date
US20050260594A1 (en) 2005-11-24
US20080200410A1 (en) 2008-08-21
EP1354060B1 (de) 2011-02-09
AU2001285157A1 (en) 2002-03-13
WO2002018645A2 (en) 2002-03-07
WO2002018645A3 (en) 2003-07-24
ATE498020T1 (de) 2011-02-15
EP1354060A2 (de) 2003-10-22

Similar Documents

Publication Publication Date Title
AU2002327308A1 (en) Methods for evaluating pathologic conditions using extracellular rna
WO2002018652A3 (en) Method for detection of htr and htert telomerase-associated rna in plasma or serum
WO2002054081A3 (en) Proteins, genes and their use for diagnosis and treatment of kidney response
WO2003028531A3 (en) Detection of tumor rna in plasma and serum
DE69933989D1 (de) Biomarker und targets für die diagnose, prognose und behandlung von prostat krankheiten
ATE420592T1 (de) Fluoreszenz vermittelte molekulare tomographie
WO2002059604A3 (en) Diagnosis and treatment of multiple sclerosis
DE60237531D1 (de) Verfahren zum trennen von seltenen zellen von fluidproben
DE60137264D1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
WO2002018651A3 (en) Methods for detecting papillomavirus dna in blood plasma and serum
DE50207866D1 (de) Verwendung löslicher cytokeratin-1-fragmente in diagnostik
WO2004031414A3 (en) Method for diagnosing prostate cancer
WO2003001183A3 (en) Methods for detecting and monitoring cox-2 rna in plasma and serum
HK1056692A1 (en) Proteins
AU2001240909A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
DE60144027D1 (de) 5t4 rna in plasma und serum als marker für neoplastische erkrankungen
WO2001062785A3 (en) Protein and gene and their use for diagnosis and treatment of schizophrenia
WO2002072752A3 (en) Forms of prostate specific antigens and methods for their detection
AU2842901A (en) Use of contrast agents in the manufacture of diagnostic agent for the visualisation of the intestinal lumen
WO2001069261A3 (en) Proteins, genes and their use for diagnosis and treatment of vascular dementia
ATE335806T1 (de) Diagnosisverfahren für whipples krankheit
WO2001096599A3 (en) Methods for quantitative determination of b-fibronectin in biological fluids and tissues
ATE420210T1 (de) Diagnose des brustkrebsrisikos
AU2002348101A1 (en) Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
WO2002054080A3 (en) Proteins, genes and their use for diagnosis and treatment of vascular response